Home > PJ (current issue) > Products | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7322 p595
23 October 2004

This article
Reprint   Photocopy

PDF 90K, Acrobat Reader


Products

    Prescription Products SPC changes Discontinued products Counter products Products miscellany

Prescription Products

Avandamet
Avandamet tablets (rosiglitazone and metformin) 2/1,000 and 4/1,000 are now available from GlaxoSmithKline. Net price,56 tablets 2mg/1,000mg £29.80, 4mg/1,000mg £56.40. Legal category: POM.

Back to Top


SPC changes

Pariet
The summary of product characteristics for Pariet (rabeprazole sodium) has been revised to include the following very rare (<1/10,000) adverse events reported from clinical trial and post-marketing experience: erythema multiforme, toxic epidermal necrolysis, Stevens-Johnson syndrome (Eisai). See SPC.

Back to Top


Discontinued products

Delfen foam
Delfen Contraceptive Foam (12.5 percent w/w of nonoxinol-9) will be discontinued from 1 November (Janssen-Cilag).

Nubain injection
Nubain (nalbuphine hydrochloride) injection is being discontinued (Bristol-Myers Squibb). Stocks are expected to be available until the end of December. Contact customer services by fax on 01244 586251.

Zantac hospital pack
Zantac (ranitidine) tablets hospital pack 150 mg is being discontinued (GlaxoSmithKline). Further details are available from the Customer Contact Centre on 0800 221 441.

Back to Top


Counter products

Numark muscle rub
Numark has launched Numark Muscle Rub (methyl salicylate) and Numark Muscle Spray (glycerol mono salicylate 5 per cent, methy salicylate 1 per cent, ethyl salicyclate 4 per cent); net prices, Muscle Rub (40g) £1.49, Muscle Spray (150ml) £2.49. Legal category: GSL.

Back to Top


Products miscellany

Mysoline
AstraZeneca will divest Mysoline 250mg to Acorus Therapeutics on 13 November. Further details on 01388 710505 (e-mail enquiries@acorus-therapeutics.com).

Levonelle One Step
Levonelle One Step (levonorgestrel 1,500µg) will be available from Schering Health Care from 1 November (PJ, 25 September, p415). Legal category: P.

Back to Top


©The Pharmaceutical Journal